CD55 may be a new target for colorectal cancer treatment

CD55 may be a new target for colorectal cancer treatment

Abstract In the early stage, our research group injected lentivirus carrying blood type A antigen into tumors as a drug, and the tumor volume of mice was significantly reduced. We speculate that the complement system plays an important role in anti-tumor therapy, but the specific components are unkn...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiong Luo, Yingjia Mao, Rong Yu, Fuqian Zhao, Hongmei Niu, Daofu Shen, Huan Tian, Lei Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Colorectal cancer
CD55
Complement system
ABO blood type
Tumor marker
Online Access:https://doi.org/10.1038/s41598-025-08491-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-08491-4

Similar Items